New Drug Approvals Archive
New Drug Approvals: February 2005
| February 11 | Vanos () Cream 0.1% Company: Medicis Treatment for Plaque-Type Psoriasis Vanos Medicis - Treatment for Plaque-Type Psoriasis |
| February 17 | Ammonul (sodium benzoate and sodium phenylacetate) Injection Date of Approval: February 17, 2005 Company: Medicis Treatment for Hyperammonemia Ammonul is a combination of 10% sodium phenylacetate and 10% sodium benzoate indicated as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. Ammonul Medicis - Treatment for Urea Cycle Disorder |
| February 18 | Vaccinia () (VIGIV) Company: DynPort Vaccine Company LLC Treatment for Complications of Smallpox Vaccination Vaccinia DynPort Vaccine Company LLC - Treatment for Complications of Smallpox Vaccination |
| February 22 | Cardura XL (doxazosin mesylate) Extended Release Tablets Date of Approval: February 22, 2005 Company: Pfizer Inc. Treatment for Benign Prostatic Hyperplasia Cardura XL is an extended release formulation providing a controlled release of doxazosin over a 24-hour period. Cardura XL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Cardura XL is not indicated for the treatment of hypertension. Cardura XL Pfizer Inc. - Treatment for Benign Prostatic Hyperplasia (BPH) |
New Drug Approvals Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec
